Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5188712
Max Phase: Preclinical
Molecular Formula: C51H63N5O9S2
Molecular Weight: 954.23
Associated Items:
ID: ALA5188712
Max Phase: Preclinical
Molecular Formula: C51H63N5O9S2
Molecular Weight: 954.23
Associated Items:
Canonical SMILES: CCN(CC)c1ccc2c(-c3ccc(S(=O)(=O)NCCCCCC(=O)NCc4cccc(C(CCNC)Oc5ccccc5OC)c4)cc3S(=O)(=O)[O-])c3ccc(=[N+](CC)CC)cc-3oc2c1
Standard InChI: InChI=1S/C51H63N5O9S2/c1-7-55(8-2)38-22-25-41-47(32-38)65-48-33-39(56(9-3)10-4)23-26-42(48)51(41)43-27-24-40(34-49(43)67(60,61)62)66(58,59)54-29-15-11-12-21-50(57)53-35-36-17-16-18-37(31-36)44(28-30-52-5)64-46-20-14-13-19-45(46)63-6/h13-14,16-20,22-27,31-34,44,52,54H,7-12,15,21,28-30,35H2,1-6H3,(H-,53,57,60,61,62)
Standard InChI Key: FBWUWTQZQBGCDE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 954.23 | Molecular Weight (Monoisotopic): 953.4067 | AlogP: 7.66 | #Rotatable Bonds: 24 |
Polar Surface Area: 182.35 | Molecular Species: ZWITTERION | HBA: 11 | HBD: 3 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -2.40 | CX Basic pKa: 9.57 | CX LogP: 2.48 | CX LogD: 2.80 |
Aromatic Rings: 4 | Heavy Atoms: 67 | QED Weighted: 0.02 | Np Likeness Score: -0.45 |
1. Camacho-Hernandez GA, Casiraghi A, Rudin D, Luethi D, Ku TC, Guthrie DA, Straniero V, Valoti E, Schütz GJ, Sitte HH, Newman AH.. (2021) Illuminating the norepinephrine transporter: fluorescent probes based on nisoxetine and talopram., 12 (7.0): [PMID:34355183] [10.1039/D1MD00072A] |
Source(1):